Key result
Sonothrombolysis combined with PCI in STEMI cuts LV remodeling ~64% versus PCI alone.
Why the study?
To evaluate the effect of sonothrombolysis on myocardial dynamics, infarct size, and its value in preventing left ventricular remodeling in patients with ST-segment-elevation myocardial infarction.
Does sonothrombolysis added to percutaneous coronary intervention improve myocardial dynamics, reduce infarct size, and prevent left ventricular remodeling in patients with ST-segment-elevation myocardial infarction?
RCT (n=100)
randomized
Does sonothrombolysis added to percutaneous coronary intervention improve myocardial dynamics, reduce infarct size, and prevent left ventricular remodeling in patients with ST-segment-elevation myocardial infarction?
Effect estimate: OR 2.79 (95% CI 0.13-6.86)
p-value: p=0.026
Sonothrombolysis as an adjunct to percutaneous coronary intervention in STEMI patients reduces microvascular obstruction, improves myocardial dynamics, and prevents left ventricular remodeling.
May limit LV remodeling after STEMI PCI; challenges prior low-certainty evidence against benefit and requires confirmation in larger trials.
Background: It has recently been demonstrated that high-energy diagnostic transthoracic ultrasound and intravenous microbubbles dissolve thrombi (sonothrombolysis) and increase angiographic recanalization rates in patients with ST-segment–elevation myocardial infarction. We aimed to study the effect of sonothrombolysis on the myocardial dynamics and infarct size obtained by real-time myocardial perfusion echocardiography and their value in preventing left ventricular remodeling. Methods: One hundred patients with ST-segment–elevation myocardial infarction were randomized to therapy (50 patients treated with sonothrombolysis and percutaneous coronary intervention) or control (50 patients treated with percutaneous coronary intervention only). Left ventricular volumes, ejection fraction, risk area (before treatment), myocardial perfusion defect over time (infarct size), and global longitudinal strain were determined by quantitative real-time myocardial perfusion echocardiography and speckle tracking echocardiography imaging. Results: Risk area was similar in the control and therapy groups (19.2±10.1% versus 20.7±8.9%; P =0.56) before treatment. The therapy group presented a behavior significantly different than control group over time ( P <0.001). The perfusion defect was smaller in the therapy at 48 to 72 hours even in the subgroup of patients with no recanalization at first angiography (12.9±6.5% therapy versus 18.8±9.9% control; P =0.015). The left ventricular global longitudinal strain was higher in the therapy than control immediately after percutaneous coronary intervention (14.1±4.1% versus 12.0±3.3%; P =0.012), and this difference was maintained until 6 months (17.1±3.5% versus 13.6±3.6%; P <0.001). The only predictor of left ventricular remodeling was treatment with sonothrombolysis: the control group was more likely to exhibit left ventricular remodeling with an odds ratio of 2.79 ([95% CI, 0.13–6.86]; P =0.026). Conclusions: Sonothrombolysis reduces microvascular obstruction and improves myocardial dynamics in patients with ST-segment–elevation myocardial infarction and is an independent predictor of left ventricular remodeling over time.
No takes yet. Share an insight, caveat, or question.
Aguiar et al. (2020) conducted an RCT in ST-segment-elevation myocardial infarction (n=100). Sonothrombolysis and percutaneous coronary intervention vs. Percutaneous coronary intervention only was evaluated on Left ventricular remodeling (OR 2.79, 95% CI 0.13-6.86, p=0.026). Sonothrombolysis combined with PCI in STEMI patients improved myocardial dynamics and reduced left ventricular remodeling compared to PCI alone (control OR 2.79; 95% CI 0.13-6.86; P=0.026).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: